Movahedan Mahsa, Brown Glen
Intensive Care Unit, St. Paul's Hospital, Vancouver, BC, Canada.
SAGE Open Med. 2025 Jul 17;13:20503121251356069. doi: 10.1177/20503121251356069. eCollection 2025.
Intravenous solutions such as dextrose 5% in water and 0.9% sodium chloride (normal saline) differ in electrolyte composition from human plasma and may contribute to serum chloride derangements (dyschloremia). This retrospective study aimed to explore the relationship between fluid composition, particularly medication diluents, and dyschloremia development in the intensive care unit.
This was a retrospective chart review of adult intensive care unit patients with normal serum chloride on admission who developed dyschloremia after 48 h of intensive care unit admission. Data were collected on fluid types and volumes administered in the intensive care unit in the 7 days prior to dyschloremia onset. Descriptive statistics and chi-square tests were used to compare characteristics between patients who developed hyperchloremia and hypochloremia.
Of 884 screened patients, 85 developed dyschloremia after 48 h (41 hypochloremia, 44 hyperchloremia). There was no significant association between the proportion of normal saline or dextrose 5% in water-containing fluids and the type of dyschloremia. However, dexmedetomidine, typically diluted in normal saline, was associated with hyperchloremia.
While total fluid composition was not associated with dyschloremia type, high-volume use of specific diluent-medication combinations may contribute. Strategies to minimize diluent volume could help reduce dyschloremia risk.
诸如5%葡萄糖水溶液和0.9%氯化钠(生理盐水)等静脉输液的电解质组成与人体血浆不同,可能导致血清氯紊乱(氯代谢异常)。这项回顾性研究旨在探讨液体组成,尤其是药物稀释剂,与重症监护病房中氯代谢异常发生之间的关系。
这是一项对成年重症监护病房患者的回顾性病历审查,这些患者入院时血清氯正常,在重症监护病房入院48小时后发生氯代谢异常。收集在氯代谢异常发作前7天内在重症监护病房给予的液体类型和体积的数据。使用描述性统计和卡方检验来比较发生高氯血症和低氯血症患者之间的特征。
在884名筛查患者中,85名在48小时后发生氯代谢异常(41名低氯血症,44名高氯血症)。生理盐水或含5%葡萄糖水溶液的液体比例与氯代谢异常类型之间没有显著关联。然而,通常用生理盐水稀释的右美托咪定与高氯血症有关。
虽然总液体组成与氯代谢异常类型无关,但特定稀释剂 - 药物组合的大量使用可能有影响。尽量减少稀释剂体积的策略可能有助于降低氯代谢异常风险。